Burkholderia pseudomallei Infections (Melioidosis) Market Share, Size, Symptoms, Treatment, Overview and Pipeline Review, H1 2016
Global Markets Direct's, 'Burkholderia pseudomallei Infections (Melioidosis) - Pipeline Review, H1 2016', provides an overview of the Burkholderia pseudomallei Infections (Melioidosis) pipeline landscape. Visit Us @ http://www.radiantinsights.com/research/burkholderia-pseudomallei-infections-melioidosis-pipeline-review-h1-2016
Global Markets Direct's, 'Burkholderia pseudomallei Infections (Melioidosis) - Pipeline Review, H1 2016', provides an overview of the Burkholderia pseudomallei Infections (Melioidosis) pipeline landscape.
Visit Us @ http://www.radiantinsights.com/research/burkholderia-pseudomallei-infections-melioidosis-pipeline-review-h1-2016
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
- The report features descriptive drug profiles for the pipeline products which includes, product description,<br />
descriptive MoA, R&D brief, licensing <strong>and</strong> collaboration details & other developmental activities<br />
- The report reviews key players involved <strong>Burkholderia</strong> <strong>pseudomallei</strong> <strong>Infections</strong> (<strong>Melioidosis</strong>) therapeutics <strong>and</strong><br />
enlists all their major <strong>and</strong> minor projects<br />
- The report assesses <strong>Burkholderia</strong> <strong>pseudomallei</strong> <strong>Infections</strong> (<strong>Melioidosis</strong>) therapeutics based on drug target,<br />
mechanism of action (MoA), route of administration (RoA) <strong>and</strong> molecule type<br />
- The report summarizes all the dormant <strong>and</strong> discontinued pipeline projects<br />
- The report reviews latest news related to pipeline therapeutics for <strong>Burkholderia</strong> <strong>pseudomallei</strong> <strong>Infections</strong><br />
(<strong>Melioidosis</strong>)<br />
Reasons To Buy<br />
- Gain strategically significant competitor information, analysis, <strong>and</strong> insights to formulate effective R&D strategies<br />
- Identify emerging players with potentially strong product portfolio <strong>and</strong> create effective counter-strategies to gain<br />
competitive advantage<br />
- Identify <strong>and</strong> underst<strong>and</strong> important <strong>and</strong> diverse types of therapeutics under development for <strong>Burkholderia</strong><br />
<strong>pseudomallei</strong> <strong>Infections</strong> (<strong>Melioidosis</strong>)<br />
- Identify potential new clients or partners in the target demographic<br />
- Develop strategic initiatives by underst<strong>and</strong>ing the focus areas of leading companies<br />
- Plan mergers <strong>and</strong> acquisitions effectively by identifying key players <strong>and</strong> it's most promising pipeline therapeutics<br />
- Devise corrective measures for pipeline projects by underst<strong>and</strong>ing <strong>Burkholderia</strong> <strong>pseudomallei</strong> <strong>Infections</strong><br />
(<strong>Melioidosis</strong>) pipeline depth <strong>and</strong> focus of Indication therapeutics<br />
- Develop <strong>and</strong> design in-licensing <strong>and</strong> out-licensing strategies by identifying prospective partners with the most<br />
attractive projects to enhance <strong>and</strong> exp<strong>and</strong> business potential <strong>and</strong> scope<br />
- Modify the therapeutic portfolio by identifying discontinued projects <strong>and</strong> underst<strong>and</strong>ing the factors that drove<br />
them from pipeline<br />
Buy a Sample Copy of This Report @ http://www.radiantinsights.com/research/burkholderia-<strong>pseudomallei</strong>infections-melioidosis-pipeline-review-h1-<strong>2016</strong>/request-sample<br />
Table of Contents<br />
Table of Contents 2<br />
List of Tables 5<br />
List of Figures 5<br />
Introduction 6<br />
Global <strong>Market</strong>s Direct Report Coverage 6<br />
<strong>Burkholderia</strong> <strong>pseudomallei</strong> <strong>Infections</strong> (<strong>Melioidosis</strong>) <strong>Overview</strong> 7<br />
Therapeutics Development 8<br />
<strong>Pipeline</strong> Products for <strong>Burkholderia</strong> <strong>pseudomallei</strong> <strong>Infections</strong> (<strong>Melioidosis</strong>) - <strong>Overview</strong> 8<br />
<strong>Pipeline</strong> Products for <strong>Burkholderia</strong> <strong>pseudomallei</strong> <strong>Infections</strong> (<strong>Melioidosis</strong>) - Comparative Analysis 9<br />
<strong>Burkholderia</strong> <strong>pseudomallei</strong> <strong>Infections</strong> (<strong>Melioidosis</strong>) - Therapeutics under Development by Companies 10<br />
<strong>Burkholderia</strong> <strong>pseudomallei</strong> <strong>Infections</strong> (<strong>Melioidosis</strong>) - Therapeutics under Investigation by Universities/Institutes 11<br />
<strong>Burkholderia</strong> <strong>pseudomallei</strong> <strong>Infections</strong> (<strong>Melioidosis</strong>) - <strong>Pipeline</strong> Products Glance 12<br />
Early Stage Products 12<br />
<strong>Burkholderia</strong> <strong>pseudomallei</strong> <strong>Infections</strong> (<strong>Melioidosis</strong>) - Products under Development by Companies 13<br />
<strong>Burkholderia</strong> <strong>pseudomallei</strong> <strong>Infections</strong> (<strong>Melioidosis</strong>) - Products under Investigation by Universities/Institutes 14<br />
<strong>Burkholderia</strong> <strong>pseudomallei</strong> <strong>Infections</strong> (<strong>Melioidosis</strong>) - Companies Involved in Therapeutics Development 15<br />
Bavarian Nordic A/S 15<br />
Emergent BioSolutions Inc. 16<br />
Grifols, S.A. 17<br />
Soligenix, Inc. 18<br />
Syntiron LLC 19<br />
<strong>Burkholderia</strong> <strong>pseudomallei</strong> <strong>Infections</strong> (<strong>Melioidosis</strong>) - Therapeutics Assessment 20
Change language